Physician

Shuang Bai, M.D.

According to 2025 Medicare claims, Shuang Bai, M.D. (NPI: 1154346799) practices internal medicine in the Los Angeles-Long Beach-Glendale, CA market, with the plurality of this provider's patient population coming from Los Angeles, CA. This provider's primary affiliated billing organization is VITAL MEDICAL CORPORATION (NPI: 1659172138) and primary practice location at 90293-8155.

Bai's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 161 traditional Medicare patients, billed 865 HCPCS/CPT codes, and received $76,670 in Medicare payments. The top billing code was 99306 (Initial nursing facility care with high level of medical decision making, per day, if using time, 50 minutes or more). Part D data shows 8,302 prescription claims across 428 beneficiaries totaling $557,970 in drug costs, led by Eliquis (Apixaban). DME data shows 96 claims. Open Payments data shows 8 records totaling $710. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $153,947 to $76,670. Similarly, Part D prescription costs have declined steadily, from $875,156 to $557,970. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $18,320 to $11,541.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	305	1,984	$153,947
2016	333	2,365	$186,387
2017	348	2,239	$180,142
2018	265	1,788	$138,240
2019	226	1,709	$134,354
2020	175	1,150	$95,490
2021	193	1,154	$99,859
2022	180	1,043	$85,553
2023	177	859	$78,675
2024	161	865	$76,670

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	453	14,196	$875,156
2016	505	15,438	$1,111,660
2017	525	14,801	$1,014,707
2018	478	13,695	$969,458
2019	438	11,189	$881,672
2020	404	10,439	$789,491
2021	411	9,058	$923,532
2022	388	8,287	$758,102
2023	426	8,154	$799,755
2024	428	8,302	$557,970

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	31	569	$52,165
2016	35	662	$56,492
2017	26	462	$57,084
2018	23	424	$36,861
2019	N/R	271	$27,793
2020	N/R	178	$8,673
2021	N/R	100	$3,128
2022	N/R	76	$2,376
2023	N/R	118	$3,889
2024	N/R	96	$4,146

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99306	Initial nursing facility care with high level of medical decision making, per day, if using time, 50 minutes or more	90	101	$136
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	15	18	$130
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	28	54	$84
99309	Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes	93	429	$83
99497	Advance care planning, first 30 minutes	61	62	$57

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	161	4,770	$92,580
Ozempic	Semaglutide	43	1,692	$43,138
Xarelto	Rivaroxaban	51	1,303	$23,496
Januvia	Sitagliptin Phosphate	15	1,110	$18,971
Budesonide	Budesonide	97	1,503	$15,827

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0260	Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress	Y	N/R	38	$1,834
K0823	Power wheelchair, group 2 standard, captains chair, patient weight capacity up to and including 300 pounds	Y	N/R	12	$1,401
K0001	Standard wheelchair	Y	N/R	34	$745
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	N/R	12	$165

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	8	$710	Phathom Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Shuang Bai, M.D.?

Tedicare shows public-source Medicare data for Shuang Bai, M.D. (NPI 1154346799), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Shuang Bai, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Shuang Bai, M.D.?

Shuang Bai, M.D. is linked to VITAL MEDICAL CORPORATION (billing NPI 1659172138) in the available physician profile data.

Does Shuang Bai, M.D. have Open Payments data?

Shuang Bai, M.D. has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.